I am deeply humbled by the decades of support from people around the world. It is an honor to share this painful yet ...
Human immunodeficiency virus-1 (HIV) is one of the most challenging viruses for doctors to treat. Even with effective ...
The Print on MSN
Cancer therapy may soon skip the lab step — and cut costs
Early data suggests single-infusion treatment can safely reprogram immune cells inside the body, opening doors to more ...
RoosterBio, Inc., a leading supplier of human mesenchymal stem/stromal cells (hMSCs), highly engineered bioprocess media, and ...
A single-dose of Trogenix’s proprietary Synthetic Super-Enhancers achieved complete tumour elimination in 83% of treated cases with no toxicity ...
The FDA has released a statement saying it will “carefully shepherd” studies to advance the development of chimeric antigen receptor T-cell therapies in autoimmune and rheumatic diseases.“It is quite ...
Human immunodeficiency virus-1 (HIV) is one of the most challenging viruses for doctors to treat.Even with effective antiretroviral therapy, immune ...
In modern drug discovery, successfully navigating the progress from molecular concept to viable therapeutic often hinges on ...
Morning Overview on MSN
One-time gene-editing treatment lowers LDL cholesterol in early trial
A single infusion of a CRISPR-based gene-editing therapy was associated with reductions in LDL cholesterol and triglycerides ...
AI-powered healthcare startup Citizen Health is using the technology to focus on rare disease, helping manage patient lives ...
Biotech executives, investors, and R&D leaders all face the same burning question in 2026: How do we scale breakthroughs from ...
A study confirms a new case of long‑term remission following a stem cell transplant from a donor with a unique genetic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results